AEON Biopharma, Inc. (AEON) — Working Capital to Net Assets Ratio
AEON Biopharma, Inc. (AEON) has a Working Capital to Net Assets ratio of 4.1% as of September 2025. Working capital of $-816.00K (current assets of $7.41 Million minus current liabilities of $8.23 Million) is measured against net assets of $-19.87 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See AEON Biopharma, Inc. (AEON) net asset quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
AEON Biopharma, Inc. Working Capital to Net Assets (2019–2024)
This chart shows how AEON Biopharma, Inc.'s Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the ratio stands at 4.1%, reflecting working capital of $-816.00K against net assets of $-19.87 Million USD. See AEON Biopharma, Inc. defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for AEON Biopharma, Inc. (2019–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for AEON Biopharma, Inc. from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of AEON Biopharma, Inc..
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 44.0% | $-12.56 Million | $-28.57 Million | $1.59 Million | $14.15 Million | ▲ +39.5 pp |
| 2023 | 4.5% | $-6.83 Million | $-153.04 Million | $6.22 Million | $13.05 Million | ▼ -22.4 pp |
| 2022 | 26.9% | $-72.74 Million | $-270.41 Million | $9.84 Million | $82.57 Million | ▲ +19.9 pp |
| 2021 | 7.0% | $-15.65 Million | $-223.82 Million | $5.15 Million | $20.80 Million | ▲ +15.0 pp |
| 2020 | -8.0% | $16.18 Million | $-203.23 Million | $20.38 Million | $4.20 Million | ▲ +135.7 pp |
| 2019 | -143.7% | $94.65 Million | $-65.87 Million | $112.14 Million | $17.50 Million | — |